CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.95 HKD | +1.46% |
|
+2.96% | -4.27% |
| Jun. 06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
| Jun. 06 | Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China | RE |
Chart calendar CSPC Pharmaceutical Group Ltd.
271d798a39e1d6b32d2c4cae91d6350._miLLffMZ1dOe-8-SfUOtWRnhf3T4VZfRPg9dkwu8yU.ixz8Q5SqDyYoSJVkfIRm7TIO57PgjBowD5FNRiNGg3fPINNsk6YAFH4VjA~e969f9ad866d9ff0f2f9e8bc1b169ac1
Upcoming events on CSPC Pharmaceutical Group Ltd.
Past events on CSPC Pharmaceutical Group Ltd.
| 2024-05-30 | Final dividend |
| 2024-05-27 10:00 pm | Annual General Meeting |
| 2024-05-26 | Q1 2024 Earnings Release |
| 2024-03-19 | Q4 2023 Earnings Release |
| 2023-11-29 | Q3 2023 Earnings Release |
| 2023-09-06 | Ex-dividend day for dividende intermédiaire |
| 2023-08-22 | Q2 2023 Earnings Release |
| 2023-06-04 | Final dividend |
| 2023-05-30 10:00 pm | Annual General Meeting |
| 2023-05-24 | Q1 2023 Earnings Release |
| 2023-05-08 | Macquarie DELTAH China Conference |
| 2023-03-21 | Q4 2022 Earnings Release |
| 2022-11-22 | Q3 2022 Earnings Release |
| 2022-09-07 | Ex-dividend day for dividende intermédiaire |
| 2022-08-23 | Interim 2022 Earnings Release |
| 2022-05-30 | Ex-dividend day for final dividend |
| 2022-05-24 | Q1 2022 Earnings Release |
| 2022-03-21 | FY 2021 Earnings Release |
| 2021-11-17 | Q3 2021 Earnings Release |
| 2021-09-09 | Ex-dividend day for dividende intermédiaire |
Past dividends on CSPC Pharmaceutical Group Ltd.
| 2024-05-30 | Final Payment 0.14 HKD |
| 2023-09-06 | Interim Payment 0.14 HKD |
| 2023-06-04 | Final Payment 0.11 HKD |
| 2022-09-07 | Interim Payment 0.1 HKD |
| 2022-05-30 | Final Payment 0.1 HKD |
| 2021-09-09 | Interim Payment 0.08 HKD |
| 2021-05-23 | Final Payment 0.09 HKD |
| 2020-09-09 | Interim Payment 0.06 HKD |
| 2020-06-17 | Annual 0.2 HKD |
| 2019-05-29 | Annual 0.18 HKD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 24 145 25 461 -5.17% | 29 762 30 540 -2.55% | 34 309 34 163 0.43% | 35 292 34 957 0.96% | 34 175 34 801 -1.8% | 37 881 |
|
EBITDA Million HKD | Released Forecast Spread | 5 789 6 284 -7.89% | 8 192 7 477 9.57% | 9 431 8 966 5.2% | 9 148 9 208 -0.66% | 8 615 9 271 -7.08% | 10 048 |
|
EBIT Million HKD | Released Forecast Spread | 5 025 5 342 -5.93% | 7 227 6 414 12.68% | 8 366 8 159 2.54% | 7 952 8 116 -2.02% | 7 400 8 079 -8.4% | 8 800 |
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 5 053 5 426 -6.87% | 7 626 6 686 14.06% | 8 430 8 370 0.72% | 8 650 8 341 3.71% | 8 030 8 336 -3.68% | 8 976 |
|
Net income Million HKD | Released Forecast Spread | 4 057 4 367 -7.09% | 6 157 5 344 15.21% | 6 901 6 873 0.41% | 6 949 6 736 3.16% | 6 382 6 692 -4.63% | 7 152 |
|
EPS HKD | Released Forecast Spread | 0,34 0,36 -6.49% | 0,52 0,47 10.05% | 0,58 0,60 -2.99% | 0,58 0,56 3.71% | 0,54 0,56 -4.57% | 0,60 |
| Announcement Date | 30/03/20 | 15/03/21 | 22/03/22 | 22/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million HKD | Released Forecast Spread | 8 883 16 823 -47.2% | 8 634 8 783 -1.69% | 8 489 9 140 -7.12% | 17 479 18 340 -4.7% | 8 938 9 062 -1.37% | 8 626 8 846 -2.49% | 8 522 8 547 -0.29% | 8 242 8 544 -3.54% | 9 690 8 073 20.04% | 9 210 | 9 637 | 9 345 | 10 429 | ||
|
EBIT Million HKD | Released Forecast Spread | 1 871 4 526 -58.65% | 1 830 1 837 -0.37% | 1 928 1 992 -3.2% | 3 697 4 290 -13.81% | 2 000 2 135 -6.3% | 2 051 1 872 9.56% | 1 865 2 011 -7.28% | 1 517 1 998 -24.06% | 2 258 1 678 34.56% | 2 085 | 2 132 | 2 042 | 2 444 | ||
|
Earnings before Tax (EBT) Million HKD | Released Forecast Spread | 2 265 2 172 4.29% | 4 379 4 336 1% | 1 977 2 201 -10.21% | 2 139 1 980 8.04% | 2 111 2 200 -4.04% | 1 934 2 169 -10.86% | 1 921 1 505 27.63% | 2 184 | 2 217 | 2 117 | |||||
|
Net income Million HKD | Released Forecast Spread | 1 657 1 791 -7.46% | 1 793 1 579 13.54% | 1 644 1 640 0.23% | 1 852 1 772 4.53% | 3 543 3 572 -0.8% | 1 586 1 787 -11.27% | 1 653 1 596 3.58% | 1 672 1 772 -5.62% | 1 498 1 761 -14.93% | 1 740 1 209 43.86% | 1 784 | 1 793 | 1 682 | ||
|
EPS HKD | Released Forecast Spread | 0,14 0,15 -7.27% | 0,15 0,34 -55.63% | 0,14 0,14 -1.1% | 0,16 0,14 9.04% | 0,30 0,28 5.29% | 0,13 0,15 -10.09% | 0,14 0,14 -1% | 0,14 0,14 -0.7% | 0,13 0,15 -12.97% | 0,15 0,13 14.7% | 0,15 | 0,15 | 0,14 | 0,16 | 0,18 |
| Announcement Date | 25/05/22 | 24/08/22 | 23/11/22 | 22/03/23 | 22/03/23 | 25/05/23 | 23/08/23 | 30/11/23 | 20/03/24 | 27/05/24 | - | - | - | - | - |
More events
Past sector events for CSPC Pharmaceutical Group Ltd.
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 1093 Stock
- Calendar CSPC Pharmaceutical Group Ltd.
